Neuralink, led by Elon Musk, has successfully conducted its first human brain implant surgery.
The implant, featuring 1024 electrodes on 64 threads, aims to enable control of digital devices by thought.
The recipient is recovering well with promising initial results.
The surgery, part of the PRIME clinical trial, targets people with quadriplegia or ALS, using a robotic surgical process.
Despite controversies over animal testing, Neuralink aspires to revolutionize human-computer interaction and aid individuals with severe physical limitations.